Understanding Stage 2 Vaginal Cancer: Symptoms, Diagnosis, and Treatment

Receiving a vaginal cancer diagnosis can feel overwhelming. This guide provides a clear overview of stage 2 vaginal cancer, including symptoms, diagnostic steps, treatment options, potential side effects and questions to discuss with your cancer care team.

What Is Stage 2 Vaginal Cancer?

Vaginal cancer is a rare malignancy that develops in the vagina, the muscular tube connecting the uterus to the external genitals. Most vaginal cancers are squamous cell carcinomas, which originate in the thin, flat cells lining the vagina. Stage 2 indicates the cancer has spread beyond the vaginal wall but has not reached the pelvic sidewall. This means the tumor is larger or has invaded deeper tissues than stage 1 but remains localized without distant spread.

Common symptoms of stage 2 vaginal cancer include abnormal vaginal bleeding, often after sexual intercourse, a noticeable mass or lump in the vagina, pain during intercourse (dyspareunia), and bloody or watery vaginal discharge. Prognosis is generally favorable, as stage 2 disease is localized and highly treatable, though outcomes depend on tumor size, location, cell type and overall health.

How Stage 2 Vaginal Cancer Is Diagnosed and Staged

Accurate diagnosis and staging are essential for planning effective treatment. Initial diagnostic procedures typically include a pelvic exam and biopsy, the latter being the only definitive method to confirm cancer. Colposcopy, which uses a magnifying instrument, may also guide tissue sampling for more precise evaluation.

Staging procedures evaluate the cancer’s spread. Cystoscopy and proctoscopy check whether the disease has reached the bladder or rectum. Imaging tests, such as CT, MRI or PET scans, help visualize the tumor, its relationship to the pelvic sidewall, and whether lymph nodes or distant organs are involved. Blood tests provide information on overall health and organ function.

Treatment Options for Stage 2 Vaginal Cancer

Radiation therapy is the mainstay treatment for stage 2 vaginal cancer, although surgery may be considered for select small tumors. The choice of treatment depends on tumor size, location, and overall health.

Radiation Therapy: Radiation uses high-energy rays to destroy cancer cells and shrink tumors. It is often preferred for stage 2 disease because it preserves vaginal structure and function. External beam radiation therapy (EBRT) delivers radiation to the pelvis and sometimes lymph nodes over several weeks. Brachytherapy, or internal radiation, places a radioactive source directly into or near the tumor, targeting cancer while limiting exposure to surrounding organs such as the bladder and rectum. These therapies are often used together for optimal results.

Concurrent Chemotherapy: Chemotherapy, often cisplatin, may be given alongside radiation to make cancer cells more sensitive to treatment. This approach is called concurrent chemo-radiation. Chemotherapy in this setting is not primarily systemic but acts to enhance radiation effectiveness.

Surgery: Surgery, such as radical vaginectomy combined with hysterectomy and lymph node removal, is less commonly used as primary therapy. It may be considered for small tumors in the upper vagina but is generally reserved for cases where radiation alone is not sufficient.

Minimally invasive surgery can offer benefits such as lower infection rates, decreased hospital stays, and less post-operative pain. However, “in certain circumstances, we would not recommend proceeding with a minimally invasive approach, and that's really individualized and based on the surgeon’s and the patient’s specific characteristics,” Dr. Jessica Parker, an assistant professor of clinical obstetrics and gynecology in the Department of Obstetrics and Gynecology at the Indiana University School of Medicine, explained in a previous CURE article.

Potential Side Effects and Management Strategies

Treatment can produce side effects, which vary depending on the modality used. Radiation therapy may cause fatigue, skin irritation, diarrhea, urinary discomfort (cystitis), rectal irritation (proctitis), and vaginal narrowing or dryness. Management includes rest, gentle skin care, use of vaginal dilators, lubricants and medications as advised by your oncology team.

Concurrent chemotherapy may lead to nausea, vomiting, fatigue, infection risk, kidney issues, hearing changes or nerve damage (neuropathy). Side effects can be managed with anti-nausea medications, careful hydration, rest, monitoring blood counts, and promptly reporting any symptoms such as numbness or tingling.

Surgery may result in short-term pain, infection, wound healing complications, lymphedema if lymph nodes are removed, changes to pelvic anatomy and loss of vaginal function. Management includes pain control, physical therapy, wound care and discussion of reconstructive options if appropriate. Early reporting of new or worsening symptoms is crucial for prevention of complications.

Questions to Discuss With Your Oncologist

Your active involvement is essential for effective care. Key questions include:

• Is my treatment plan primarily radiation, or will it involve concurrent chemotherapy? What is the rationale for this approach?
• What are the details of my radiation plan, including doses, number of treatments, and the use of EBRT versus brachytherapy?
• How will treatment affect sexual function, and what steps, such as vaginal dilator use, can help maintain quality of life?
• Will treatment impact fertility, and what preservation options are available if needed?
• What does the long-term follow-up schedule look like, and how often will I need check-ups?

Informed discussions with your gynecologic oncologist, combined with a strong support system and attention to physical and mental health, are central to navigating stage 2 vaginal cancer and optimizing outcomes.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

References

1. “Pros and Cons of Surgery Approaches in Gynecologic Cancers,” by Ashley Chan. CURE; Sept. 10, 2024. https://www.curetoday.com/view/pros-and-cons-of-surgery-approaches-in-gynecologic-cancers

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.